First Manhattan’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-90
Closed -$19.4K 739
2024
Q1
$19.4K Hold
90
﹤0.01% 1038
2023
Q4
$23.3K Sell
90
-70
-44% -$18.1K ﹤0.01% 1001
2023
Q3
$41.1K Sell
160
-1
-0.6% -$257 ﹤0.01% 911
2023
Q2
$45.9K Hold
161
﹤0.01% 901
2023
Q1
$44.8K Buy
161
+1
+0.6% +$278 ﹤0.01% 929
2022
Q4
$44.3K Buy
160
+40
+33% +$11.1K ﹤0.01% 965
2022
Q3
$32K Hold
120
﹤0.01% 1001
2022
Q2
$24K Hold
120
﹤0.01% 1080
2022
Q1
$25K Hold
120
﹤0.01% 1120
2021
Q4
$28K Hold
120
﹤0.01% 1108
2021
Q3
$33K Sell
120
-940
-89% -$259K ﹤0.01% 1067
2021
Q2
$367K Buy
1,060
+940
+783% +$325K ﹤0.01% 616
2021
Q1
$33K Sell
120
-10
-8% -$2.75K ﹤0.01% 1040
2020
Q4
$31K Sell
130
-19
-13% -$4.53K ﹤0.01% 981
2020
Q3
$42K Sell
149
-36
-19% -$10.1K ﹤0.01% 903
2020
Q2
$49K Hold
185
﹤0.01% 878
2020
Q1
$58K Buy
185
+65
+54% +$20.4K ﹤0.01% 821
2019
Q4
$35K Sell
120
-51
-30% -$14.9K ﹤0.01% 949
2019
Q3
$39K Hold
171
﹤0.01% 939
2019
Q2
$39K Sell
171
-61
-26% -$13.9K ﹤0.01% 965
2019
Q1
$54K Buy
232
+112
+93% +$26.1K ﹤0.01% 938
2018
Q4
$36K Hold
120
﹤0.01% 979
2018
Q3
$42K Hold
120
﹤0.01% 1013
2018
Q2
$34K Hold
120
﹤0.01% 1014
2018
Q1
$32K Sell
120
-1,010
-89% -$269K ﹤0.01% 1024
2017
Q4
$359K Buy
1,130
+410
+57% +$130K ﹤0.01% 596
2017
Q3
$225K Hold
720
﹤0.01% 653
2017
Q2
$195K Hold
720
﹤0.01% 682
2017
Q1
$196K Buy
720
+50
+7% +$13.6K ﹤0.01% 692
2016
Q4
$189K Buy
670
+70
+12% +$19.7K ﹤0.01% 675
2016
Q3
$187K Hold
600
﹤0.01% 679
2016
Q2
$145K Hold
600
﹤0.01% 736
2016
Q1
$156K Hold
600
﹤0.01% 706
2015
Q4
$183K Hold
600
﹤0.01% 694
2015
Q3
$175K Hold
600
﹤0.01% 692
2015
Q2
$242K Hold
600
﹤0.01% 652
2015
Q1
$253K Sell
600
-15
-2% -$6.33K ﹤0.01% 644
2014
Q4
$208K Buy
615
+15
+3% +$5.07K ﹤0.01% 691
2014
Q3
$198K Sell
600
-39
-6% -$12.9K ﹤0.01% 689
2014
Q2
$201K Sell
639
-411
-39% -$129K ﹤0.01% 681
2014
Q1
$321K Sell
1,050
-15
-1% -$4.59K ﹤0.01% 592
2013
Q4
$297K Sell
1,065
-48
-4% -$13.4K ﹤0.01% 604
2013
Q3
$267K Sell
1,113
-485
-30% -$116K ﹤0.01% 615
2013
Q2
$345K Buy
+1,598
New +$345K ﹤0.01% 558